HyperlyteCR (B. Braun Medical Inc.)
Welcome to the PulseAid listing for the Hyperlyte drug offered from B. Braun Medical Inc.. This Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | B. Braun Medical Inc. |
| NON-PROPRIETARY NAME: | Multi Electrolyte Concentrate |
| SUBSTANCE NAME: | POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM ACETATE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2012-04-12 |
| END MARKETING DATE: | 0000-00-00 |
Hyperlyte CR HUMAN PRESCRIPTION DRUG Details:
| Item Description | Hyperlyte CR from B. Braun Medical Inc. |
| LABELER NAME: | B. Braun Medical Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.96; 1.17; .68; .51; .37(g/20mL; g/20mL; g/20mL; g/20mL; g/20mL) |
| START MARKETING DATE: | 2012-04-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0264-1943_799c5123-e3fb-4311-94db-274870603a52 |
| PRODUCT NDC: | 0264-1943 |
| APPLICATION NUMBER: | |
Other POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM ACETATE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
